Emergency Medicine Pharmacy Specialty Review Course, Workbook Chapters, and Practice Exam (No Recert Credit) (Cert # L229261)

The American Society of Health-System Pharmacists and the American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These activities are intended for pharmacists who are seeking to update their knowledge and skills commensurate with a board certification examination in the areas listed below.

This course consists of 21 activities (see table below) and provides up to 25 contact hours of continuing pharmacy education credit. The Review Course includes case-based presentations for application to real-life scenarios, a practice exam along with correct answers, and links to the reference sources, and domains, tasks, and knowledge statements to help you prepare for the BPS Specialty Examination. 

       

Learning Activity	ACPE Number	Contact Hours	Expiration Date
Complex Case: Pulmonary	0204-9999-22-984-H01-P	1.50	6/15/2025
Complex Case: Cardiovascular - ACS	0204-9999-22-985-H01-P	1.00
Complex Case: Cardiovascular - Acute Decompensated Heart Failure	0204-9999-22-986-H01-P	1.00
Complex Case: Cardiovascular - Dysrhythmia	0204-9999-22-987-H01-P	1.00
Complex Case: Seizures and Status Epilepticus	0204-9999-22-988-H01-P	1.00
Complex Case: Headache	0204-9999-22-989-H01-P	1.00
Complex Case: Ischemic Stroke	0204-9999-22-990-H01-P	1.00
Complex Case: Psychiatry	0204-9999-22-991-H01-P	1.50
Complex Case: Hepato-gastrointestinal	0204-9999-22-992-H01-P	1.00
Complex Case: Endocrine	0204-9999-22-993-H01-P	1.00
Complex Case: Infectious Diseases - Sepsis	0204-9999-22-994-H01-P	1.50
Complex Case: Infectious Diseases - Meningitis	0204-9999-22-995-H01-P	1.00
Complex Case: Toxicology - Adult	0204-9999-22-996-H01-P	1.50
Complex Case: Toxicology - Pediatric	0204-9999-22-997-H01-P	1.50
Complex Case: Surgery and Trauma - Blunt Trauma	0204-9999-22-998-H01-P	1.50
Complex Case: Surgery and Trauma - Penetrating Trauma	0204-9999-22-999-H01-P	1.00
Complex Case: Genitourinary	0204-9999-22-600-H01-P	1.00
Complex Case: Obstetrics and Gynecology	0204-9999-22-601-H01-P	1.00
Complex Case: Hematology	0204-9999-22-602-H01-P	1.00
Complex Case: Oncology	0204-9999-22-603-H01-P	1.00
Statistics, Evidence-based Medicine, and Research Design	0204-9999-22-905-H04-P	2.00	3/4/2025

After participating in this CPE activity, learners should be able to: 

Complex Case: Pulmonary
ACPE #: 0204-9999-22-984-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices).
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Adjust patient-centered care plan based upon response, monitoring and patient-specific information.
• Identify adverse drug events and medication errors in emergency medicine.
• Evaluate protocols for adherence to evidence-based guidelines to assure safe and cost effective medication use and optimal resource allocation. 

Complex Case: Cardiovascular – ACS
ACPE #: 0204-9999-22-985-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices, pre-hospital providers).
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Assess applicability and limitations of published data and reports to care of patient.
• Modify treatment plan based upon monitoring patient’s response to initial therapy. 

Complex Case: Cardiovascular - Acute Decompensated Heart Failure
ACPE #: 0204-9999-22-986-H01-P

• Assess patient presentation based upon patient-specific signs, symptoms, acuity indices, laboratory and other diagnostic results.
• Evaluate medication-related problems based on presentation, history (e.g., pre-hospital providers), medication use, and/or laboratory data.
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Modify treatment plan based upon monitoring patient’s response to initial therapy. 

Complex Case: Cardiovascular – Dysrhythmia
ACPE #: 0204-9999-22-987-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices, pre-hospital providers).
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Modify treatment plan based upon monitoring patient’s response to initial therapy. 

Complex Case: Seizures and Status Epilepticus
ACPE #: 0204-9999-22-988-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices, pre-hospital providers).
• Evaluate medication-related problems based on presentation, history (e.g., pre-hospital providers), medication use, and laboratory data.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Modify treatment plan based upon patient’s response to initial therapy. 

Complex Case: Headache
ACPE #: 0204-9999-22-989-H01-P

• Evaluate medication-related problems based on presentation, history (e.g., pre-hospital providers), medication use, and laboratory data.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Modify treatment plan based upon monitoring patient’s response to initial therapy.
• Develop education, discharge and follow-up care plans based upon patient- and disease specific factors to improve adherence and continuity of care. 

Complex Case: Ischemic Stroke
ACPE #: 0204-9999-22-990-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices).
• Evaluate medication-related problems based on presentation, history (e.g., pre-hospital providers), medication use, and laboratory data.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Modify treatment plan based upon monitoring patient’s response to initial therapy. 

Complex Case: Psychiatry
ACPE #: 0204-9999-22-991-H01-P

• Interpret signs, symptoms, laboratory and other diagnostic and acuity results.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Select alternative routes of administration based upon patient-specific factors.
• Modify treatment plan based upon monitoring patient’s response to initial therapy.
• Assess applicability and limitations of published data and reports to care of patient. 

Complex Case: Hepato-gastrointestinal
ACPE #: 0204-9999-22-992-H01-P

• Interpret signs, symptoms, laboratory and other diagnostic and acuity results.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Select alternative routes of administration based upon patient-specific factors.
• Modify treatment plan based upon monitoring patient’s response to initial therapy. 

Complex Case: Endocrine
ACPE #: 0204-9999-22-993-H01-P

• Interpret signs, symptoms, laboratory and other diagnostic and acuity results.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Select alternative routes of administration based upon patient-specific factors.
• Modify treatment plan based upon monitoring patient’s response to initial therapy.
• Develop education, discharge and follow-up care plans based upon patient- and disease specific factors to improve adherence and continuity of care. 

Complex Case: Infectious Diseases – Sepsis
ACPE #: 0204-9999-22-994-H01-P

• Develop therapeutic and monitoring plans based on medication-related, patient- and disease-specific information, laboratory data, and available evidence.
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Modify treatment plan based upon patient’s response to initial therapy and stewardship guidelines.
• Evaluate medication use protocols for adherence to evidence-based guidelines.
• Identify principles of quality assurance and continuous quality improvement (e.g., RAC, MUE). 

Complex Case: Infectious Diseases – Meningitis
ACPE #: 0204-9999-22-995-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices).
• Interpret signs, symptoms, laboratory and other diagnostic and acuity results.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Select alternative routes of administration based upon patient-specific factors.
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Modify treatment plan based upon monitoring patient’s response to initial therapy. 

Complex Case: Toxicology – Adult
ACPE #: 0204-9999-22-996-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices).
• Develop therapeutic and monitoring plans based on medication-related, patient- and disease-specific information, and laboratory data.
• Interpret signs, symptoms, and laboratory and other relevant diagnostic test results.
• Evaluate policies and processes for availability of essential drugs (e.g., drug shortages).
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Modify treatment plan based upon monitoring patient’s response to initial therapy. 

Complex Case: Toxicology – Pediatric
ACPE #: 0204-9999-22-997-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices).
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Evaluate policies and processes for availability of essential drugs (e.g., drug shortages) and emergency preparedness.
• Modify treatment plan based upon patient’s response to initial therapy. 

Complex Case: Surgery and Trauma - Blunt Trauma
ACPE #: 0204-9999-22-998-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, medication use, acuity indices).
• Interpret signs, symptoms, and laboratory and other diagnostic test results.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Modify treatment plan based upon monitoring the patient’s response to initial therapy. 

Complex Case: Surgery and Trauma - Penetrating Trauma
ACPE #: 0204-9999-22-999-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, medication use, and acuity indices).
• Interpret signs, symptoms, acuity indices, laboratory and other diagnostic results (e.g., pre-hospital care).
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Select alternative routes of administration based upon patient-specific factors.
• Modify treatment plan based upon patient’s response to initial therapy. 

Complex Case: Genitourinary
ACPE #: 0204-9999-22-600-H01-P

• Interpret signs, symptoms, and laboratory and other relevant diagnostic test results.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Develop discharge and follow-up care plans based upon patient- and disease specific factors and public health recommendations to ensure continuity of care. 

Complex Case: Obstetrics and Gynecology
ACPE #: 0204-9999-22-601-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, relevant acuity indices) and best available evidence.
• Interpret signs, symptoms, and laboratory and other relevant diagnostic test results.
• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Modify treatment plan based upon monitoring the patient’s response to initial therapy. 

Complex Case: Hematology
ACPE #: 0204-9999-22-602-H01-P

• Develop therapeutic and monitoring plans based on medication-related problems, patient- and disease-specific information, and laboratory data.
• Modify treatment plan based upon monitoring the patient’s response to initial therapy.
• Develop discharge and follow-up care plans based upon patient- and disease specific factors to improve adherence and continuity of care. 

Complex Case: Oncology
ACPE #: 0204-9999-22-603-H01-P

• Identify initial management in medical emergencies using available patient-specific information (e.g., age-related, risk factors, laboratory data).
• Summarize strategies for procurement, preparation, and administration of time-sensitive therapies.
• Modify treatment plan based upon monitoring the patient’s response to initial therapy. 

Statistics, Evidence-based Medicine, and Research Design
ACPE #: 0204-9999-22-604-H04-P

Given an excerpt from a study:

• Evaluate quality and appropriateness of the excerpt, with specific attention to:
  • study design
  • statistical analysis
  • internal/external validity
  • source of bias/confounders
  • quality of conclusions
  • interpretation of graphs
• Explain why a statistical test is appropriate or not appropriate, based on the sample distribution, data type, and study design.
• Interpret clinical and statistical significance for results from commonly used statistical tests.
• Explain the strengths and limitations of different types of measures of central tendency (mean, median, and mode) and data spread (standard deviation, standard error of the mean, range, and interquartile range).
• Evaluate odds ratio, risk/incidence rate, relative risk, number needed to treat, number needed to harm, and other risk estimates.
• Assess whether the study applies to a specified patient population.

Heather Draper, PharmD, BCPS*
Clinical Pharmacy Specialist, Emergency Medicine
Mercy Health Saint Mary's
Grand Rapids, Michigan 

Ryan Feldman, PharmD, BCPS, DABAT
Emergency Medicine Pharmacist
Froedtert Health
Medical College of Wisconsin
Clinical Toxicologist
Milwaukee, Wisconsin 

Curtis Geier, PharmD, BCCCP
Emergency Medicine Clinical Pharmacist
Zuckerberg San Francisco General Hospital/San Francisco
Department of Public Health
Assistant Clinical Professor
University of California San Francisco
San Francisco, California 

Josh Heffren, PharmD, BCPPS
Pharmacy Operations Supervisor, Emergency Medicine
Children's National Hospital
Washington, DC 

Daniel Jarrell, PharmD, BCCCP, BCPS
Clinical Pharmacist - Emergency Medicine
Banner University Medical Center – Tucson
Clinical Assistant Professor, Department of Pharmacy Practice
University of Arizona
Tucson, Arizona 

Elizabeth (Libby) Johnson, PharmD, BCPS
Critical Care Supervisor and Emergency Medicine Clinical Pharmacist
JPS Health Network
Fort Worth, Texas 

Jenny Koehl, PharmD, BCPS
Attending Emergency Medicine Clinical Pharmacist
Massachusetts General Hospital
Boston, Massachusetts 

Maggie Ma, PharmD, BCPS
Clinical Pharmacy Specialist, Emergency Medicine
The University of Texas at MD Anderson Cancer Center
Houston, Texas 

Melinda Mendez, PharmD, BCPS
Clinical Pharmacy Specialist - Emergency Medicine
The Johns Hopkins Hospital
Baltimore, Maryland 

Megan Musselman, PharmD, MS, BCPS, BCCCP
PGY2 Emergency Medicine Residency Program Director
North Kansas City Hospital
Kansas City, Missouri 

Melinda Ortmann, PharmD, BCPS*
Clinical Pharmacy Specialist - Emergency Medicine
The Johns Hopkins Hospital
Baltimore, Maryland 

Marianne Pop, PharmD, MPH, BCPS
Clinical Assistant Professor
University of Illinois Chicago College of Pharmacy
EM Clinical Pharmacist
OSF Saint Anthony Medical Center
Rockford, Illinois 

Gabrielle Procopio, PharmD, BCPS
Emergency Medicine Clinical Pharmacist
Hackensack University Medical Center
Assistant Professor of Emergency Medicine
Hackensack Meridian School of Medicine
Hackensack, New Jersey 

Elizabeth (Liz) Rozycki, PharmD, BCPS
Specialty Practice Pharmacist, Emergency Medicine
Ohio State University Wexner Medical Center
Columbus, Ohio 

Andrew Smith, PharmD, MBA, BCPS, BCCCP
Emergency Medicine Clinical Pharmacist Specialist
Scripps Mercy San Diego
San Diego, California 

Heather Tilley, PharmD
Emergency Medicine Clinical Pharmacist
Children's National Hospital
Washington, DC 

Kyle Weant, PharmD, BCPS, BCCCP, FCCP
Clinical Assistant Professor
University of South Carolina College of Pharmacy
Emergency Medicine Clinical Pharmacy Specialist
Prisma Health Richland
Columbia, South Carolina 

David Zimmerman, PharmD, BCCCP*
Associate Professor of Pharmacy
Duquesne University
Emergency Medicine Pharmacist
University of Pittsburgh Medical Center-Mercy
Pittsburgh, Pennsylvania 

Juliana Zschoche, PharmD, BCPS
Clinical Pharmacy Specialist, Emergency Medicine
The Johns Hopkins Hospital
Baltimore, Maryland 

* Content Matter Experts

Holly L. Byrnes, PharmD, BCPS
Susan R. Dombrowski, MS, RPh

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

The following persons in control of this activity’s content have relevant financial relationships:

• David Zimmerman: Spero Therapeutics; Grant recipient

• Marianne Pop: TerSera Therapeutics; Consultant

All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP and ACCP. 

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.